Publication
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity
| dc.contributor.author | Camões-Barbosa, A | |
| dc.contributor.author | Ribeiro, I | |
| dc.contributor.author | Medeiros, L | |
| dc.date.accessioned | 2019-12-05T11:51:05Z | |
| dc.date.available | 2019-12-05T11:51:05Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin. Contralateral weakness after botulinum toxin A treatment is a rarely reported adverse effect. We report the case of a 33-year-old female who had been receiving regular injections of incobotulinum toxin A due to spasticity of the right limbs after a hemorrhagic stroke. A switch was made to abobotulinum toxin A with an overall conversion ratio of 1:3.83. The patient presented contralateral upper limb paresis, especially of the deltoid muscle, in the second week post-injection. The electroneuromyography showed neuromuscular block due to botulinum toxin A. She recovered completely after eight months. A switch between different formulations of botulinum toxin type A should prompt caution when carrying out unit conversions. Distant side effects may appear, including paresis in the contralateral limbs. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Acta Med Port , 32 (13) 2019 Apr 26[Online ahead of print] | pt_PT |
| dc.identifier.doi | 10.20344/amp.11503 | pt_PT |
| dc.identifier.issn | 1646-0758 | |
| dc.identifier.uri | http://hdl.handle.net/10400.10/2331 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Ordem dos Médicos | pt_PT |
| dc.relation.publisherversion | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/viewFile/11503/5804 | pt_PT |
| dc.subject | Botulinum toxins type A | pt_PT |
| dc.subject | Muscle weakness | pt_PT |
| dc.title | Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity | pt_PT |
| dc.title.alternative | Paresia do Membro Superior Contralateral Após Infiltração de Toxina Botulínica A para Espasticidade Pós-AVC | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Lisboa | pt_PT |
| oaire.citation.title | Acta Médica Portuguesa | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |